MCCORMICK FRANK 4
4 · BridgeBio Pharma, Inc. · Filed Dec 28, 2023
Insider Transaction Report
Form 4
MCCORMICK FRANK
Director
Transactions
- Sale
Common Stock
2023-12-26$42.06/sh−100,000$4,206,000→ 627,689 total(indirect: See Footnote)
Holdings
- 472,376
Common Stock
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person, as Trustee of the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 on June 15, 2023.
- [F2]Represents the weighted average sale price of the shares sold from $42.00 to $42.25 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F3]By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017.